GRDN on NYSE
Guardian Pharmacy Services, Inc.
American Retail-Drug Stores and Proprietary Stores company.
Price unavailable
Last updated Oct 18, 2026.
Overview
Compare with 111, Inc., PetMed Express or Ridgetech Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
20.2%Gross margin2
5.0%Operating margin2
3.4%Net margin2
17.9%Revenue growth, 20252
22.6%Return on equity2
0.00×Debt to equity2
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue80¢$1.2B
- Selling, general and admin15¢$220.0M
- Income tax2¢$24.5M
- Profit3¢$49.2M
Out of $1.4B in revenue.2
Where each dollar of operating cash went, fiscal 2025
- Kept or used elsewhere100¢$100.3M
Out of $100.3M of cash from operations.2
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.2
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenues | $1.4B | $1.2B |
| Cost of goods sold | $1.2B | $984.0M |
| Gross profit | $292.7M | $244.4M |
| Selling, general, and administrative expenses | $220.0M | $307.3M |
| Operating income (loss) | $72.7M | -$62.9M |
| Interest expense | $665.0K | $3.3M |
| Other expense (income), net | -$1.4M | $279.0K |
| Total other expenses (income) | -$722.0K | $3.6M |
| Income (loss) before income taxes | $73.4M | -$66.5M |
| Provision for income taxes | $24.5M | $4.6M |
| Net income (loss) | $49.0M | -$71.0M |
| Less net income attributable to Guardian Pharmacy, LLC prior to the Corporate Reorganization | $0 | $22.8M |
| Less net income (loss) attributable to non-controlling interests | -$261.0K | $16.3M |
| Net income (loss) attributable to Guardian Pharmacy Services, Inc. | $49.2M | -$110.0M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $65.6M | $4.7M | |
| Accounts receivable, net | $101.6M | $97.2M | |
| Inventories | $43.4M | $40.5M | |
| Other current assets | $11.0M | $9.6M | |
| Total current assets | $221.6M | $152.0M | |
| Property and equipment, net | $55.5M | $49.9M | |
| Intangible assets, net | $18.5M | $14.9M | |
| Goodwill | $79.7M | $69.3M | |
| Operating lease right-of-use assets | $34.6M | $29.1M | |
| Deferred tax assets | $2.2M | $5.3M | |
| Other assets | $436.0K | $383.0K | |
| Total assets | $412.7M | $320.8M | |
| Accounts payable | $116.2M | $102.4M | |
| Accrued compensation | $15.0M | $14.4M | |
| Operating leases, current portion | $7.2M | $6.8M | |
| Other current liabilities | $22.3M | $20.4M | |
| Total current liabilities | $160.7M | $144.1M | |
| Operating leases, net of current portion | $30.0M | $23.3M | |
| Other liabilities | $4.0M | $3.4M | |
| Total liabilities | $194.7M | $170.8M | |
| Members' equity | $0 | $0 | |
| Additional paid-in capital | $139.4M | $125.5M | |
| Retained earnings | $66.3M | $17.1M | |
| Non-controlling interests | $12.2M | $7.3M | |
| Total equity | $217.9M | $150.0M | $59.9M |
| Total liabilities and equity | $412.7M | $320.8M |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $65.6M | $4.7M | |
| Accounts receivable, net | $101.6M | $97.2M | |
| Inventories | $43.4M | $40.5M | |
| Other current assets | $11.0M | $9.6M | |
| Total current assets | $221.6M | $152.0M | |
| Property and equipment, net | $55.5M | $49.9M | |
| Intangible assets, net | $18.5M | $14.9M | |
| Goodwill | $79.7M | $69.3M | |
| Operating lease right-of-use assets | $34.6M | $29.1M | |
| Deferred tax assets | $2.2M | $5.3M | |
| Other assets | $436.0K | $383.0K | |
| Total assets | $412.7M | $320.8M | |
| Accounts payable | $116.2M | $102.4M | |
| Accrued compensation | $15.0M | $14.4M | |
| Operating leases, current portion | $7.2M | $6.8M | |
| Other current liabilities | $22.3M | $20.4M | |
| Total current liabilities | $160.7M | $144.1M | |
| Operating leases, net of current portion | $30.0M | $23.3M | |
| Other liabilities | $4.0M | $3.4M | |
| Total liabilities | $194.7M | $170.8M | |
| Members' equity | $0 | $0 | |
| Additional paid-in capital | $139.4M | $125.5M | |
| Retained earnings | $66.3M | $17.1M | |
| Non-controlling interests | $12.2M | $7.3M | |
| Total equity | $217.9M | $150.0M | $59.9M |
| Total liabilities and equity | $412.7M | $320.8M |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.2
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income (loss) | $49.0M | -$71.0M |
| Depreciation and amortization | $22.3M | $19.8M |
| Share-based compensation expense | $13.8M | $131.5M |
| Provision for losses on accounts receivable | $4.6M | $6.4M |
| Change in deferred tax asset | $3.1M | $0 |
| Other | $1.1M | $767.0K |
| Accounts receivable | -$8.6M | -$25.5M |
| Inventories | -$877.0K | -$1.2M |
| Other current assets | -$2.5M | -$2.0M |
| Accounts payable | $16.4M | $13.2M |
| Accrued compensation | $618.0K | -$3.0M |
| Other operating liabilities | $1.3M | -$11.1M |
| Net cash provided by operating activities | $100.3M | $58.0M |
| Purchases of property and equipment | -$19.5M | -$16.4M |
| Payment for acquisitions | -$13.4M | -$14.7M |
| Other | $736.0K | $671.0K |
| Net cash used in investing activities | -$32.2M | -$30.4M |
| Proceeds from equity offering, net of underwriter fees | $29.0M | $119.8M |
| Payments of equity offering costs | -$1.6M | -$4.2M |
| Borrowings from notes payable | $0 | $15.0M |
| Repayment of notes payable | -$497.0K | -$38.0M |
| Borrowings from line of credit | $0 | $189.3M |
| Repayments of line of credit | $0 | -$198.3M |
| Principal payments on finance lease obligations | -$4.5M | -$4.5M |
| Payments related to acquisitions | -$2.5M | $0 |
| Contributions from non-controlling interests | $2.0M | $2.8M |
| Distributions to non-controlling interests | -$458.0K | -$14.5M |
| Member distributions | $0 | -$35.8M |
| Other | $500.0K | -$160.0K |
| Net cash used in financing activities | -$7.1M | -$23.6M |
| Net change in cash and cash equivalents | $61.0M | $3.9M |
| Cash paid during the year for interest | $650.0K | $3.1M |
| Cash paid during the year for income taxes | $21.5M | $0 |
| Purchases of property and equipment through finance leases | $4.9M | $3.5M |
| Accrued and capitalized offering costs recorded to additional paid-in capital | $0 | $8.9M |
| Non-cash equity contributions from non-controlling members | $3.6M | $5.6M |
No quarter-by-quarter statement was filed.
Compare Guardian Pharmacy Services, Inc. with another company
Leadership
Who has led Guardian Pharmacy Services, Inc., and when. Pick a name to see everywhere that person has worked.
Board members and other officers (17)
- OfficerChris Crisafulli Apr 13, 2026 to now8
- OfficerDavid Norman Martin Apr 13, 2026 to now9
- OfficerDouglas Towns Apr 13, 2026 to now10
- OfficerJeffrey Tuch Apr 13, 2026 to now11
- Senior Vice President, SalesRichard Eakins Apr 13, 2026 to now12
- OfficerRobert Weir Apr 13, 2026 to now13
- Senior Vice President, FinanceWilliam Franklin Mudd Apr 13, 2026 to now14
- OfficerDavid K. Morris Sep 25, 2024 to now15
- OfficerFred Burke Sep 25, 2024 to now16
- OfficerKendall Forbes Sep 25, 2024 to now17
- Board memberDavid K. Morris Sep 25, 2024 to now15
- Board memberFred Burke Sep 25, 2024 to now16
- Board memberMary Sue Patchett Sep 25, 2024 to now18
- Board memberRandall J. Lewis Sep 25, 2024 to now19
- Board memberSteven D. Cosler Sep 25, 2024 to now20
- Board memberThomas J. Salentine Jr. Sep 25, 2024 to now21
- Board memberWilliam E. Bindley Sep 25, 2024 to now22
Former names
- Guardian Pharmacy, LLCFeb 13, 2020 to Jul 23, 20213
Filings
214 filings to the SEC since October 2021: 2 annual reports, 6 quarterly reports, 24 major events, 101 insider forms, 40 large holders, 41 other. The latest 20:
- Sep 28, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 28, 2026SCHEDULE 13D/A EDGAR
- Sep 28, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 10, 20268-K EDGAR
- Aug 6, 202610-Q EDGAR
- Aug 6, 20268-K EDGAR
The 214 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 40 such filings since October 2021, the latest 10:
- Sep 28, 2026SCHEDULE 13D/A
- May 6, 2026SCHEDULE 13G
- Mar 24, 2026SCHEDULE 13D/A
- Feb 13, 2026SCHEDULE 13G/A
- Feb 10, 2026SCHEDULE 13G/A
- Jan 21, 2026SCHEDULE 13G/A
- Nov 14, 2025SCHEDULE 13G/A
- Nov 12, 2025SCHEDULE 13G
- Oct 17, 2025SCHEDULE 13G
- Aug 12, 2025SCHEDULE 13G/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Fmr LLC | 3,241,612 | $135.7M | 0.0% | +882,255 |
| Wellington Management Group Llp | 1,729,032 | $72.4M | 0.0% | −36,087 |
| BlackRock, Inc. | 1,575,989 | $66.0M | 0.0% | −180,385 |
| Vanguard Capital Management LLC | 1,379,750 | $57.8M | 0.0% | +154,207 |
| Woodline Partners LP | 1,306,340 | $54.7M | 0.2% | +22 |
| Valiant Capital Management, L.P. | 1,186,658 | $49.7M | 3.1% | No change |
| Boston Partners | 983,868 | $40.8M | 0.0% | −33,815 |
| Franklin Resources Inc | 966,206 | $40.5M | 0.0% | +13,254 |
| TimesSquare Capital Management, LLC | 951,637 | $39.8M | 0.6% | −125,837 |
| Loomis Sayles & Co L P | 869,836 | $36.4M | 0.0% | −61,853 |
| Boone Capital Management LLC | 711,939 | $29.8M | 7.0% | +80,746 |
| Geode Capital Management, LLC | 646,695 | $27.1M | 0.0% | +87,660 |
| Jennison Associates LLC | 626,664 | $26.2M | 0.0% | −196,120 |
| State Street Corp | 590,114 | $24.7M | 0.0% | +81,096 |
| Brown Advisory Inc | 524,013 | $21.9M | 0.0% | −735,161 |
| Dimensional Fund Advisors LP | 516,094 | $21.6M | 0.0% | +307,500 |
| Driehaus Capital Management LLC | 510,161 | $21.4M | 0.1% | −78,960 |
| First Trust Advisors LP | 461,307 | $19.3M | 0.0% | +367,630 |
| Aristotle Capital Boston, LLC | 422,427 | $17.7M | 1.2% | −73,429 |
| Silvercrest Asset Management Group LLC | 345,229 | $14.5M | 0.1% | −29,717 |
| Braun Stacey Associates Inc | 339,947 | $14.2M | 0.4% | New |
| Morgan Stanley | 312,004 | $13.1M | 0.0% | +195,036 |
| Raymond James Financial Inc | 307,879 | $12.9M | 0.0% | +46,860 |
| Royal Bank Of Canada | 301,400 | $12.6M | 0.0% | +299,899 |
| Alyeska Investment Group, L.P. | 275,000 | $11.5M | 0.0% | No change |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARChris Crisafulli, Officer
- 9SEC EDGARDavid Norman Martin, Officer
- 10SEC EDGARDouglas Towns, Officer
- 11SEC EDGARJeffrey Tuch, Officer
- 12
- 13SEC EDGARRobert Weir, Officer
- 14
- 15SEC EDGARDavid K. Morris, Officer
- 16SEC EDGARFred Burke, Officer
- 17SEC EDGARKendall Forbes, Officer
- 18SEC EDGARMary Sue Patchett, Board member
- 19SEC EDGARRandall J. Lewis, Board member
- 20SEC EDGARSteven D. Cosler, Board member
- 21
- 22SEC EDGARWilliam E. Bindley, Board member